None
Quote | Guardant Health Inc. (NASDAQ:GH)
Last: | $29.48 |
---|---|
Change Percent: | 0.1% |
Open: | $29.06 |
Close: | $29.48 |
High: | $30 |
Low: | $28.74 |
Volume: | 923,910 |
Last Trade Date Time: | 06/25/2024 03:00:00 am |
News | Guardant Health Inc. (NASDAQ:GH)
2024-06-21 23:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-11 13:45:23 ET Summary We are revisiting oncology testing company Exact Sciences Corporation today for the first time in nearly a year and a half. The shares have been cut by more than half since last summer, despite revenue growth in the low teens and strong support from ...
Message Board Posts | Guardant Health Inc. (NASDAQ:GH)
Subject | By | Source | When |
---|---|---|---|
GH(-34%/AH)reports_results_of Shield ctDNA(liquid biopsy)diagnostic_for co | DewDiligence | investorshub | 12/16/2022 12:06:13 AM |
I'm still feeling very good about owning this | jerseyboy | investorshub | 04/01/2021 10:10:37 PM |
I like the nice, gradual, consistent rise in | jerseyboy | investorshub | 12/21/2020 10:49:18 PM |
So am I. This is THE company I | jerseyboy | investorshub | 11/27/2020 12:09:11 AM |
2-3 years I'm thinking this is @ 3-5X | PR_12 | investorshub | 11/12/2020 3:48:48 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-06-21 23:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Upgraded gene panel on tissue genomic profiling test covers 498 biomarkers, including guideline-recommended genes Operational improvements streamline workflow and shorten time to results Upgraded test covered by Medicare for comprehensive genomic profiling of all advanced solid tu...
2024-06-04 07:00:06 ET Kyle Mikson from Canaccord Genuity issued a price target of $38.00 for GH on 2024-06-04 05:20:00. The adjusted price target was set to $38.00. At the time of the announcement, GH was trading at $27.41. The overall price target consensus is at $58.2...